Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference.
about
PharmGKB summary: very important pharmacogene information for UGT1A1Mendelian randomization studies: a review of the approaches used and the quality of reportingRelationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum DisordersBilirubin is independently associated with oxidized LDL levels in young obese patients.Serum bilirubin concentration is modified by UGT1A1 haplotypes and influences risk of type-2 diabetes in the Norfolk Island genetic isolate.Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.Relationship between Cardiovascular Risk Score and Traditional and Nontraditional Cardiometabolic Parameters in Obese Adolescent Girls.Higher direct bilirubin levels during mid-pregnancy are associated with lower risk of gestational diabetes mellitus.Metabolic abnormalities in Williams-Beuren syndrome.Serum bilirubin and the risk of hypertension.Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study.Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach.Mendelian randomization: where are we now and where are we going?Low Bilirubin Levels Indicate a High Risk of Cerebral Deep White Matter Lesions in Apparently Healthy Subjects.
P2860
Q24562836-1597791F-7764-4D74-A9BE-F8CFBF94BED2Q26999349-8D8651CD-EE75-4E9C-B1DC-4DFC0DF2AE70Q33662898-139D75E0-D8F4-4ADC-8A5F-F95D3F757F30Q35599188-5D7F3DBB-36F1-4B20-B7CE-77CE1701D629Q35858211-19DC4D97-BD19-4D24-9D28-6635B272E4D8Q36951478-CAE45E48-71C0-46DB-96DA-AFFACC7E4E0AQ37694947-0792BD93-FB33-49E0-AFE6-190B7C3D1DA2Q40547202-E9D1CA64-12F2-4AD5-A221-DA0EDAB3172AQ41461696-553F1933-9D13-4A7F-8D9E-CEE072146B3EQ41648528-EBB52204-B282-4BC1-91F9-6FCC97674631Q42243725-757444C3-6735-403C-8419-6C249088BC67Q44728568-1A53263E-F0C7-4C3F-9186-7C53C265A5D5Q47132536-C54FAF39-212C-4D2E-AFD4-5A708204889CQ48456096-7704B889-E0E3-4380-809E-A971B5540F23Q55264979-84B25C62-2F69-42C0-8BB0-A061024B429C
P2860
Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Association between bilirubin ...... on to assess causal inference.
@ast
Association between bilirubin ...... on to assess causal inference.
@en
Association between bilirubin ...... on to assess causal inference.
@nl
type
label
Association between bilirubin ...... on to assess causal inference.
@ast
Association between bilirubin ...... on to assess causal inference.
@en
Association between bilirubin ...... on to assess causal inference.
@nl
prefLabel
Association between bilirubin ...... on to assess causal inference.
@ast
Association between bilirubin ...... on to assess causal inference.
@en
Association between bilirubin ...... on to assess causal inference.
@nl
P2093
P2860
P356
P1476
Association between bilirubin ...... on to assess causal inference.
@en
P2093
Afshin Parsa
Brian W Whitcomb
Keith Tanner
Patrick F McArdle
P2860
P2888
P356
10.1186/1471-2261-12-16
P577
2012-03-14T00:00:00Z
P5875
P6179
1044116755